Purple Biotech Ltd. Balance Sheet 2011-2024 | PPBT

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-6.76 M	-10.6 M	-1.31 M	-193 K	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	199 K	207 K	195 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	953 K	313 K	405 K	1.52 M	256 K	185 K	-	-	-	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	4.05 M	3.86 M	3.72 M	5.59 M	1.53 M	1.38 M	986 K	1.26 M	-	-
Deferred Revenue	-	-	961 K	-	95 K	-	-	-	-	-	-
Retained Earnings	-	-77.5 M	-49.5 M	-43.7 M	-38.6 M	-26.2 M	-14.1 M	-9.85 M	-4.6 M	-	-
Total Assets	70.2 M	83.8 M	14.7 M	14.7 M	14.2 M	14.9 M	10.8 M	1.76 M	311 K	-	-
Cash and Cash Equivalents	10.9 M	11.2 M	4.38 M	5.16 M	3.95 M	6.76 M	10.6 M	-	-	-	-
Book Value	70.2 M	79.8 M	10.9 M	11 M	8.59 M	13.4 M	9.43 M	773 K	-946 K	-	-
Total Shareholders Equity	-	79.8 M	10.9 M	11 M	8.69 M	13.4 M	9.43 M	773 K	-	-	-

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	550 K	-	-	-	688 K	-	-	-	28 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	842 K	-	-	-	953 K	-	-	-	313 K	-	388 K	-	405 K	-	470 K	-	1.52 M	-	-	-	256 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-95.9 M	-	-	-	-77.5 M	-	-	-	-49.5 M	-	-46.2 M	-	-43.7 M	-	-43.3 M	-	-38.5 M	-	-	-	-26.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	70.2 M	-	-	-	83.8 M	-	-	-	14.7 M	-	17.2 M	-	14.7 M	-	18.4 M	-	14.2 M	-	-	-	14.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	10.9 M	-	-	-	11.2 M	-	-	-	4.38 M	-	2.76 M	-	5.16 M	-	5.36 M	-	3.95 M	-	527 K	-	6.76 M	-	-	-	10.6 M	-	-	-	1.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	70.2 M	-	-	-	83.8 M	-	-	-	14.7 M	-	17.2 M	-	14.7 M	-	18.4 M	-	14.2 M	-	-	-	14.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	65.1 M	-	-	-	79.8 M	-	-	-	10.9 M	-	11.4 M	-	11 M	-	10.7 M	-	8.69 M	-	12.5 M	-	13.4 M	-	-	-	9.43 M	-	-	-	773 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-